153 related articles for article (PubMed ID: 33295807)
21. The comparative trial of TCu 380A IUD and progesterone-releasing vaginal ring used by lactating women.
Chen JH; Wu SC; Shao WQ; Zou MH; Hu J; Cong L; Miao L; Wang C; Dong J; Gao J; Xiao BL
Contraception; 1998 Jun; 57(6):371-9. PubMed ID: 9693396
[TBL] [Abstract][Full Text] [Related]
22. Factors associated with postpartum use of long-acting reversible contraception.
Oduyebo T; Zapata LB; Boutot ME; Tepper NK; Curtis KM; D'Angelo DV; Marchbanks PA; Whiteman MK
Am J Obstet Gynecol; 2019 Jul; 221(1):43.e1-43.e11. PubMed ID: 30885772
[TBL] [Abstract][Full Text] [Related]
23. Comparing methods of long-acting reversible contraception: A qualitative study of Delaware women's perceptions of intrauterine devices and the implant.
Manzer JL; Berndt VK; Bell AV
Contraception; 2022 Sep; 113():73-77. PubMed ID: 35417755
[TBL] [Abstract][Full Text] [Related]
24. Choices and services related to contraception in the Gaza strip, Palestine: perceptions of service users and providers.
Böttcher B; Abu-El-Noor M; Abu-El-Noor N
BMC Womens Health; 2019 Dec; 19(1):165. PubMed ID: 31856794
[TBL] [Abstract][Full Text] [Related]
25. Exploring the Uptake of Long-Acting Reversible Contraception in South Dakota Women and the Importance of Provider Education.
Weber TL; Briggs A; Hanson JD
S D Med; 2017 Nov; 70(11):493-497. PubMed ID: 29088520
[TBL] [Abstract][Full Text] [Related]
26. Ugandan Women's View of the IUD: Generally Favorable but Many Have Misperceptions About Health Risks.
Twesigye R; Buyungo P; Kaula H; Buwembo D
Glob Health Sci Pract; 2016 Aug; 4 Suppl 2(Suppl 2):S73-82. PubMed ID: 27540127
[TBL] [Abstract][Full Text] [Related]
27. Predictors of contraceptive switching and discontinuation within the first 6 months of use among Highly Effective Reversible Contraceptive Initiative Salt Lake study participants.
Simmons RG; Sanders JN; Geist C; Gawron L; Myers K; Turok DK
Am J Obstet Gynecol; 2019 Apr; 220(4):376.e1-376.e12. PubMed ID: 30576664
[TBL] [Abstract][Full Text] [Related]
28. Louisiana and Mississippi Family Physicians' Contraception Counseling for Adolescents with a Focus on Intrauterine Contraception.
Rubin SE; Coy LN; Yu Q; Muncie HL
J Pediatr Adolesc Gynecol; 2016 Oct; 29(5):458-463. PubMed ID: 26872714
[TBL] [Abstract][Full Text] [Related]
29. A bright future for IUDS: new technology and research trigger expanded interest.
Netw Res Triangle Park N C; 1991 Sep; 12(2):1, 4-5. PubMed ID: 12284272
[TBL] [Abstract][Full Text] [Related]
30. Barriers and Solutions to Improve Adolescent Intrauterine Device Access.
Espey E; Yoder K; Hofler L
J Pediatr Adolesc Gynecol; 2019 Sep; 32(5S):S7-S13. PubMed ID: 31585618
[TBL] [Abstract][Full Text] [Related]
31. Do Knowledge and Attitudes Regarding Intrauterine Devices Predict Interest in Their Use?
Gomez AM; Hartofelis EC; Finlayson S; Clark JB
Womens Health Issues; 2015; 25(4):359-65. PubMed ID: 26025424
[TBL] [Abstract][Full Text] [Related]
32. Immediate postplacental insertion of GYNE-T 380 and GYNE-T 380 postpartum intrauterine contraceptive devices: randomized study.
Tatum HJ; Beltran RS; Ramos R; Van Kets H; Sivin I; Schmidt FH
Am J Obstet Gynecol; 1996 Nov; 175(5):1231-5. PubMed ID: 8942493
[TBL] [Abstract][Full Text] [Related]
33. Six-month and 1-year continuation rates following postpartum insertion of implants and intrauterine devices.
Woo I; Seifert S; Hendricks D; Jamshidi RM; Burke AE; Fox MC
Contraception; 2015 Dec; 92(6):532-5. PubMed ID: 26408376
[TBL] [Abstract][Full Text] [Related]
34. Mental health diagnoses and early removal of long-acting reversible contraception.
Bello JK; Salas J; Meyer D; Heiden-Rootes K; Davis DM; Keegan Garrett E; White MM; Schmeidler P
J Affect Disord; 2020 Feb; 262():333-336. PubMed ID: 31740110
[TBL] [Abstract][Full Text] [Related]
35. Characteristics of women in the United States who use long-acting reversible contraceptive methods.
Kavanaugh ML; Jerman J; Hubacher D; Kost K; Finer LB
Obstet Gynecol; 2011 Jun; 117(6):1349-1357. PubMed ID: 21606745
[TBL] [Abstract][Full Text] [Related]
36. Barriers to Intrauterine Device Uptake in a Rural Setting in Ghana.
Robinson N; Moshabela M; Owusu-Ansah L; Kapungu C; Geller S
Health Care Women Int; 2016; 37(2):197-215. PubMed ID: 25153448
[TBL] [Abstract][Full Text] [Related]
37. Intimate Partner Violence and Effectiveness Level of Contraceptive Selection Post-Abortion.
Drew LB; Mittal M; Thoma ME; Harper CC; Steinberg JR
J Womens Health (Larchmt); 2020 Aug; 29(8):1142-1149. PubMed ID: 31721639
[No Abstract] [Full Text] [Related]
38. Factors Associated with New Uptake of Long-Acting Reversible Contraceptives Since the Affordable Care Act Among Privately Insured Women in Pennsylvania.
Nelson HN; Thayer E; Bailey C; Leuenberger L; Lehman E; Chuang CH
Womens Health Issues; 2019; 29(5):370-375. PubMed ID: 31337530
[TBL] [Abstract][Full Text] [Related]
39. No Perfect Method: Exploring How Past Contraceptive Methods Influence Current Attitudes Toward Intrauterine Devices.
Gomez AM; Arteaga S; Aronson N; Goodkind M; Houston L; West E
Arch Sex Behav; 2020 May; 49(4):1367-1378. PubMed ID: 31429033
[TBL] [Abstract][Full Text] [Related]
40. Long-acting reversible contraception knowledge, attitudes and use among HIV-infected and -uninfected women and their providers.
Teodoro N; Fu A; Ohly NT; Shalev N; Matseoane-Peterssen D; Westhoff CL
Contraception; 2019 Oct; 100(4):269-274. PubMed ID: 31226320
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
